Cargando…
SARS-CoV-2 vaccination improves HBV seroconversion rate through heterological immunity
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
International Society of Nephrology. Published by Elsevier Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624106/ https://www.ncbi.nlm.nih.gov/pubmed/36332726 http://dx.doi.org/10.1016/j.kint.2022.10.012 |
| _version_ | 1784822160881090560 |
|---|---|
| author | Anft, Moritz Paniskaki, Krystallenia Giglio, Tina Wellenkötter, Jacqueline Blazquez-Navarro, Arturo Meister, Toni L. Roch, Toralf Giesecke-Thiel, Claudia Westhoff, Timm H. Stervbo, Ulrik Pfaender, Stephanie Cinkilic, Okan Babel, Nina |
| author_facet | Anft, Moritz Paniskaki, Krystallenia Giglio, Tina Wellenkötter, Jacqueline Blazquez-Navarro, Arturo Meister, Toni L. Roch, Toralf Giesecke-Thiel, Claudia Westhoff, Timm H. Stervbo, Ulrik Pfaender, Stephanie Cinkilic, Okan Babel, Nina |
| author_sort | Anft, Moritz |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9624106 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | International Society of Nephrology. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96241062022-11-02 SARS-CoV-2 vaccination improves HBV seroconversion rate through heterological immunity Anft, Moritz Paniskaki, Krystallenia Giglio, Tina Wellenkötter, Jacqueline Blazquez-Navarro, Arturo Meister, Toni L. Roch, Toralf Giesecke-Thiel, Claudia Westhoff, Timm H. Stervbo, Ulrik Pfaender, Stephanie Cinkilic, Okan Babel, Nina Kidney Int Letter to the Editor International Society of Nephrology. Published by Elsevier Inc. 2023-01 2022-11-01 /pmc/articles/PMC9624106/ /pubmed/36332726 http://dx.doi.org/10.1016/j.kint.2022.10.012 Text en © 2022 International Society of Nephrology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Anft, Moritz Paniskaki, Krystallenia Giglio, Tina Wellenkötter, Jacqueline Blazquez-Navarro, Arturo Meister, Toni L. Roch, Toralf Giesecke-Thiel, Claudia Westhoff, Timm H. Stervbo, Ulrik Pfaender, Stephanie Cinkilic, Okan Babel, Nina SARS-CoV-2 vaccination improves HBV seroconversion rate through heterological immunity |
| title | SARS-CoV-2 vaccination improves HBV seroconversion rate through heterological immunity |
| title_full | SARS-CoV-2 vaccination improves HBV seroconversion rate through heterological immunity |
| title_fullStr | SARS-CoV-2 vaccination improves HBV seroconversion rate through heterological immunity |
| title_full_unstemmed | SARS-CoV-2 vaccination improves HBV seroconversion rate through heterological immunity |
| title_short | SARS-CoV-2 vaccination improves HBV seroconversion rate through heterological immunity |
| title_sort | sars-cov-2 vaccination improves hbv seroconversion rate through heterological immunity |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624106/ https://www.ncbi.nlm.nih.gov/pubmed/36332726 http://dx.doi.org/10.1016/j.kint.2022.10.012 |
| work_keys_str_mv | AT anftmoritz sarscov2vaccinationimproveshbvseroconversionratethroughheterologicalimmunity AT paniskakikrystallenia sarscov2vaccinationimproveshbvseroconversionratethroughheterologicalimmunity AT gigliotina sarscov2vaccinationimproveshbvseroconversionratethroughheterologicalimmunity AT wellenkotterjacqueline sarscov2vaccinationimproveshbvseroconversionratethroughheterologicalimmunity AT blazqueznavarroarturo sarscov2vaccinationimproveshbvseroconversionratethroughheterologicalimmunity AT meistertonil sarscov2vaccinationimproveshbvseroconversionratethroughheterologicalimmunity AT rochtoralf sarscov2vaccinationimproveshbvseroconversionratethroughheterologicalimmunity AT gieseckethielclaudia sarscov2vaccinationimproveshbvseroconversionratethroughheterologicalimmunity AT westhofftimmh sarscov2vaccinationimproveshbvseroconversionratethroughheterologicalimmunity AT stervboulrik sarscov2vaccinationimproveshbvseroconversionratethroughheterologicalimmunity AT pfaenderstephanie sarscov2vaccinationimproveshbvseroconversionratethroughheterologicalimmunity AT cinkilicokan sarscov2vaccinationimproveshbvseroconversionratethroughheterologicalimmunity AT babelnina sarscov2vaccinationimproveshbvseroconversionratethroughheterologicalimmunity |